SAG
RNAM

SageView Advisory Group’s Avidity Biosciences RNAM Stock Holding History

SageView Advisory Group’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-45
Closed -$3.25K – 2035
2025
Q4 		$3.25K Buy
+45
New +$2.91K ﹤0.01% 2088

Other funds holding RNAM

CC
Corsicana & Co Corsicana, Texas $206M AUM 26.42% 1-Year Est. Return

SageView Advisory Group's RNAM Position: Q1 2026 in Review

SageView Advisory Group sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 45 shares — an estimated $3.25K sold.

SageView Advisory Group first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $3.25K in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • SageView Advisory Group reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • SageView Advisory Group sold 45 Avidity Biosciences shares in Q1 2026, an estimated $3.25K.
  • SageView Advisory Group first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
  • SageView Advisory Group's Avidity Biosciences position peaked at $3.25K in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on SageView Advisory Group's 13F filing for Q1 2026, filed 10 Aug 2026.